Related Experiment Video
Updated: Aug 3, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Benzodiazepine modulation of opiate reward
1Department of Psychology, University of California, Santa Barbara 93106, USA.
Abstract:
Case studies reveal that opiate addicts often premedicate themselves with benzodiazepine (BDZ) tranquilizers prior to taking their opiate. It has been hypothesized that such actions occur because the BDZ enhances the euphoric or reinforcing properties of the opiate. The present study tested this hypothesis in the animal laboratory. Sprague-Dawley rats were used to examine whether the magnitude of conditioned preferences for a distinctive environment associated with intravenous heroin delivery would be augmented by intraperitoneal alprazolam pretreatment. Results demonstrated that alprazolam produced a leftward shift of the heroin dose-response curve in the conditioned place preference test. The data obtained are consistent with the view that BDZs can augment the affective response to heroin in laboratory animals.
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

